Company attributes
Location
B2X
Legal Name
EpiVax Oncology Inc.
Legal classification
Date Incorporated
2017
Spun Out From
Number of Employees (Ranges)
1 – 10
Full Address
188 Valley St Ste 424 Providence, RI, 02909-2468 United States
CIK Number
Investors
Founded Date
2017
Total Funding Amount (USD)
2,775,000
Latest Funding Round Date
October 2019
Business Model
Commerce
Latest Funding Type
Other attributes
Company Operating Status
Active
EpiVax Oncology is a biotech company founded in 2017 and specializes in Precision medicine, Biotechnology, and Cancer Immunotherapy. The company also specializes in designing vaccines that may activate the body’s T cells to cure or prevent diseases in the host.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
